Characterization and IL-15 dependence of NK cells in humanized mice

被引:34
作者
Pek, Elisabeth A. [1 ]
Chan, Tiffany [1 ]
Reid, Sarah [1 ]
Ashkar, Ali A. [1 ]
机构
[1] McMaster Univ, Ctr Gene Therapeut, Dept Pathol & Mol Med, Hlth Sci Ctr, Hamilton, ON L8N 3Z5, Canada
关键词
NK cells; NCRs; IL-15; Humanized mice; NATURAL-KILLER-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; IMMUNE-SYSTEM; INTERLEUKIN-15; INFECTION; DIFFERENTIATION; RECEPTORS; CYTOKINES; NKP44; NKG2D;
D O I
10.1016/j.imbio.2010.04.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural Killer cells can distinguish between healthy and malignant cells and have the unique ability to lyse tumour cells without prior sensitization. Differences between murine and human NK cells complicate the translation of this knowledge into useful therapeutics. Humanized mouse models that support the development of human leukocytes are a promising avenue of research that aims to address this problem. Here we provide an in-depth phenotypic analysis of human NK cells in Balb/c Rag2(-/-)gamma(-/-)(c) mice reconstituted with human hematopoietic stem cells. We have examined the development of NK cells in bone marrow, thymous, spleen, lymph node (LN) and liver. Interestingly, in naive reconstituted mice, NK cells were found in thymus and LN, but not in bone marrow. These NK cells expressed several inhibitory and activating receptors needed for malignant cell detection. Furthermore, we confirm that administration of recombinant human interleukin-15 (rhIL-15) or Ad-vector expressing hIL-15 is able to significantly enhance NK cell development and maturation, particularly in bone marrow and liver, in this model. Our results suggest that human NK cells developed in mice may have phenotypes and tissue distributions similar to those seen in human. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:218 / 224
页数:7
相关论文
共 35 条
[1]   Interleukin-15 and NK1.1+ Cells Provide Innate Protection against Acute Salmonella enterica Serovar Typhimurium Infection in the Gut and in Systemic Tissues [J].
Ashkar, Ali A. ;
Reid, Sarah ;
Verdu, Elena F. ;
Zhang, Kun ;
Coombes, Brian K. .
INFECTION AND IMMUNITY, 2009, 77 (01) :214-222
[2]   HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/- (RAG-hu) mouse model [J].
Berges, Bradford K. ;
Wheat, William H. ;
Palmer, Brent E. ;
Connick, Elizabeth ;
Akkina, Ramesh .
RETROVIROLOGY, 2006, 3 (1)
[3]  
Biassoni Roberto, 2009, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1410s84
[4]   NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J].
Cantoni, C ;
Bottino, C ;
Vitale, M ;
Pessino, A ;
Augugliaro, R ;
Malaspina, A ;
Parolini, S ;
Moretta, L ;
Moretta, A ;
Biassoni, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) :787-795
[5]   Potential role for interleukin-15 in the regulation of human natural killer cell survival [J].
Carson, WE ;
Fehniger, TA ;
Haldar, S ;
Eckhert, K ;
Lindemann, MJ ;
Lai, CF ;
Croce, CM ;
Baumann, H ;
Caligiuri, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (05) :937-943
[6]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[7]   Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice [J].
Chen, Qingfeng ;
Khoury, Maroun ;
Chen, Jianzhu .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (51) :21783-21788
[8]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[9]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[10]   NK cell and DC interactions [J].
Cooper, MA ;
Fehniger, TA ;
Fuchs, A ;
Colonna, M ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2004, 25 (01) :47-52